Cancer Survivor… Now Investor
In 1988, I graduated from the University of Notre Dame.
That summer, I walked into a Urologist’s office and told him I thought I needed a tumor removed from my testicle. I was right.
After removing my testicle, at the time, the traditional next step was a lymphoid dissection which had cautionary tales as they were located danger close to my reproductive organs.
I was given the choice of surgery, or go into a study at Dana Farber Cancer Institute in Boston, where a Harvard Doctor would review markers of my frequent blood testing to see if the cancer had spread. A 70% historical no find of additional cancer from surgery was an easy decision for a young guy, no girlfriend and always wanted a family.
That process etched a memory, of compassionate nurses, happy kids with cancer and the role of testing and science seeing improved cancer outcomes.
Well, I survived and today I am the finder of investments for a Hedge Fund. In our diversified portfolio are several companies seeking Cannabis solutions to cancer treatment, maybe one day prevention. Example: One World Cannabis Pharmaceuticals has a Harvard Doctor, in a prestigious Israel hospital, is studying a topical cream for melanoma and PTSD treatment utilizing Cannabis.
Every day I thank God for surviving. Recently, I walked away from a lunch with the leadership team of the company thinking, wouldn’t it be awesome if my current investment one day brought relief and solutions to my kids or someone I know?
When we discuss students, we always mention their qualities. Those qualities show what they are…
If you or someone you know is juggling mental health issues alongside substance abuse, understanding…
For the last couple of weeks, the Israel-Hamas conflict has taken over the news cycle.…
Our eyes are invaluable, serving as our windows to the world. The ability to see…
Undoubtedly, one of the most demanding and challenging professions is nursing. Nurses work long hours in…
Echocardiography, or echo for short, is a key diagnostic test used by cardiologists to assess…